Dayton Clinical Oncology Program | Dayton, OH
Research site
Site insights
Top conditions
Top treatments
Bevacizumab
Paclitaxel
Carboplatin
Lenalidomide
Cyclophosphamide
Trastuzumab
Dexamethasone
Doxorubicin Hydrochloride
Leucovorin Calcium
Cisplatin
Parent organization
This site is a part of Dayton Clinical Oncology Program
Data sourced from clinicaltrials.gov
Contact this site
Amy Dempe
Verified by this site
Active trials
1 of 80 total trials
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen depriva...
Active, not recruiting
Prostate Cancer
Drug: Bicalutamide
Drug: TAK-700
Trial sponsors
G
U
C
G
G
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems